These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38422816)

  • 41. Experience with the treatment of argininosuccinic aciduria during pregnancy.
    Reid L; Perreault E; Lafrance G; Clarke JT
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S191-5. PubMed ID: 19585269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Argininosuccinate lyase deficiency: longterm outcome of 13 patients detected by newborn screening.
    Ficicioglu C; Mandell R; Shih VE
    Mol Genet Metab; 2009 Nov; 98(3):273-7. PubMed ID: 19635676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interallelic complementation in an inborn error of metabolism: genetic heterogeneity in argininosuccinate lyase deficiency.
    McInnes RR; Shih V; Chilton S
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4480-4. PubMed ID: 6589607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early allograft dysfunction in a pediatric liver allograft with an occult pathogenic mutation in the urea cycle.
    Rezvani M; Campbell KM; Prada CE; Peters AL
    Am J Transplant; 2023 May; 23(5):673-675. PubMed ID: 36870389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Argininosuccinate lyase deficiency (ASL) and carbohydrate-deficient transferrin (CDT): experience with four independent CDT analysis methods--misleading results given by the %CDT TIA assay.
    Arndt T; Gressner A; Herwig J; Meier U; Sewell AC
    Clin Chim Acta; 2006 Nov; 373(1-2):117-20. PubMed ID: 16808909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene.
    Trevisson E; Salviati L; Baldoin MC; Toldo I; Casarin A; Sacconi S; Cesaro L; Basso G; Burlina AB
    Hum Mutat; 2007 Jul; 28(7):694-702. PubMed ID: 17326097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular analysis of human argininosuccinate lyase: mutant characterization and alternative splicing of the coding region.
    Walker DC; McCloskey DA; Simard LR; McInnes RR
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9625-9. PubMed ID: 2263616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A mouse model of argininosuccinic aciduria: biochemical characterization.
    Reid Sutton V; Pan Y; Davis EC; Craigen WJ
    Mol Genet Metab; 2003 Jan; 78(1):11-6. PubMed ID: 12559843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intragenic complementation and the structure and function of argininosuccinate lyase.
    Yu B; Howell PL
    Cell Mol Life Sci; 2000 Oct; 57(11):1637-51. PubMed ID: 11092456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expanding the phenotype in argininosuccinic aciduria: need for new therapies.
    Baruteau J; Jameson E; Morris AA; Chakrapani A; Santra S; Vijay S; Kocadag H; Beesley CE; Grunewald S; Murphy E; Cleary M; Mundy H; Abulhoul L; Broomfield A; Lachmann R; Rahman Y; Robinson PH; MacPherson L; Foster K; Chong WK; Ridout DA; Bounford KM; Waddington SN; Mills PB; Gissen P; Davison JE
    J Inherit Metab Dis; 2017 May; 40(3):357-368. PubMed ID: 28251416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intragenic complementation at the human argininosuccinate lyase locus. Identification of the major complementing alleles.
    Walker DC; Christodoulou J; Craig HJ; Simard LR; Ploder L; Howell PL; McInnes RR
    J Biol Chem; 1997 Mar; 272(10):6777-83. PubMed ID: 9045711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model.
    Daly O; Mahiny AJ; Majeski S; McClintock K; Reichert J; Boros G; Szabó GT; Reinholz J; Schreiner P; Reid S; Lam K; Lepper M; Adler M; Meffen T; Heyes J; Karikó K; Lutwyche P; Vlatkovic I
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Argininosuccinate lyase deficiency: evidence for heterogeneous structural gene mutations by immunoblotting.
    Simard L; O'Brien WE; McInnes RR
    Am J Hum Genet; 1986 Jul; 39(1):38-51. PubMed ID: 3752080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Argininosuccinate lyase in enterocytes protects from development of necrotizing enterocolitis.
    Premkumar MH; Sule G; Nagamani SC; Chakkalakal S; Nordin A; Jain M; Ruan MZ; Bertin T; Dawson B; Zhang J; Schady D; Bryan NS; Campeau PM; Erez A; Lee B
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G347-54. PubMed ID: 24904080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical, enzymatic, and molecular genetic characterization of a biochemical variant type of argininosuccinic aciduria: prenatal and postnatal diagnosis in five unrelated families.
    Kleijer WJ; Garritsen VH; Linnebank M; Mooyer P; Huijmans JG; Mustonen A; Simola KO; Arslan-Kirchner M; Battini R; Briones P; Cardo E; Mandel H; Tschiedel E; Wanders RJ; Koch HG
    J Inherit Metab Dis; 2002 Sep; 25(5):399-410. PubMed ID: 12408190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene.
    Yang S; Cheng YS; Li R; Pradhan M; Hong J; Beers J; Zou J; Liu C; Might M; Rodems S; Zheng W
    Stem Cell Res; 2019 Aug; 39():101496. PubMed ID: 31326749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular genetics of urea cycle diseases].
    Ohtake A; Mori M
    Seikagaku; 1990 Sep; 62(9):1170-7. PubMed ID: 2258657
    [No Abstract]   [Full Text] [Related]  

  • 58. Functional Characterization of Argininosuccinate Lyase Gene Variants by Mini-Gene Splicing Assay.
    Wang Y; Sun Y; Liu M; Zhang X; Jiang T
    Front Genet; 2019; 10():436. PubMed ID: 31156699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resting energy expenditure in argininosuccinic aciduria and in other urea cycle disorders.
    Brambilla A; Bianchi ML; Cancello R; Galimberti C; Gasperini S; Pretese R; Rigoldi M; Tursi S; Parini R
    J Inherit Metab Dis; 2019 Nov; 42(6):1105-1117. PubMed ID: 31056765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The incidence of movement disorder increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria.
    Gurung S; Karamched S; Perocheau D; Seunarine KK; Baldwin T; Alrashidi H; Touramanidou L; Duff C; Elkhateeb N; Stepien KM; Sharma R; Morris A; Hartley T; Crowther L; Grunewald S; Cleary M; Mundy H; Chakrapani A; Batzios S; Davison J; Footitt E; Tuschl K; Lachmann R; Murphy E; Santra S; Uudelepp ML; Yeo M; Finn PF; Cavedon A; Siddiqui S; Rice L; Martini PGV; Frassetto A; Heales S; Mills PB; Gissen P; Clayden JD; Clark CA; Eaton S; Kalber TL; Baruteau J
    J Inherit Metab Dis; 2023 Dec; ():. PubMed ID: 38044746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.